W. Distler

Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.

J. Cuzick, A. Howell, A. Buzdar, 2006, The Lancet. Oncology.

Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.

W. Distler, S. Albrecht, T. Zimmermann, 2000, Luminescence : the journal of biological and chemical luminescence.

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

M. Lena, F. Peradotto, P. Koralewski, 2007 .